Corbevax Gets Emergency Use Nod For Children Aged 12-18 Yrs


New Delhi: Hyderabad-based pharmaceutical giant Biological E Ltd’s coronavirus vaccine Corbevax granted an emergency use approval for use in children aged 12 to 18 years.

The Drug Controller General of India (DCGI) on Monday permitted emergency uses authorisation and with this, Corbevax became India’s third homegrown vaccine, to receive an emergency use approval in India for use in adolescents.

BE said it had received the approval for restricted use in an emergency situation in adolescents aged 12 years to less than 18 years based on interim results of its ongoing Phase II/III clinical study.

DCGI had already approved Corbevax for restricted use in an emergency situation for adults on December 28, 2021.

Comments are closed.